So what the Keystone Mine is unavailable, put it this way let's say It was real estate and you owned 50 properties and one of them burns down. You still have 49 other properties to make money off of.

Why is everyone calling Joel a liar, you all act like you know something. The only one giving any information is Joel. Most 0.0001 stocks don't say anything at all for years on end. This one will be a winner. Trust in Joel and trust in $MNGG

In My Honest Opinion - Joel is a Genius! This company will buy me a dream home in the future - cant wait. GO $MNGG

Recently the company told everyone that they were broke and couldnt repay their loan. The company closed their doors, sent all employees home and shut down operations. The Lenders got together and held an auction, I think just about everything was sold or bought out however I read a conflicting story stating that nobody showed up at the auction except for the lender. The only thing this company still has is the patent rights to the technology. No operations or revenue generating items but this is all in my head dont make a trade because of me. Speculative Buy - Hold and see if someone comes in and scoops it up to make something happen. Never Know and just so everyone knows I am invested but small position with 95K shares.

The CEO of this company is a genius.

What is making this thing rise today? No News or Anything from what I can see. Just spontaneous burst of energy lol

Purely my opinion just to start. What I think will happen is the vote will take place, the YES's will have it and more shares will be issued. Due to shareholder outrage the stock will pull back to the $4-5 range and the NEJM publishing reports we have all been waiting for will be released shooting this stock into the $15-20 range during the Phase II trials giving ACTC the funding to get them to the next level. IMHO this stock will trade Super High $000 3 digit numbers when its fully functional and bringing in cash. This stock is a true WINNER for the Long Term Investor but it will take multiple years and lots of What If, OMGS, WTFs to get there. The NEJM articles will counter balance the A/S increase and the uplisting to a major exchange will be the game changer again all IMO.

How would they R/S a stock that already has unlimited shares?

PAID PUMP?

Last Time I Picked AXXE They Ran Upwards From
.21 Levels To .245 Just A Few Days Later

Ticker: AXXE



Axxess Pharma, Inc.

Symbol: AXXE

Price: $.1998




Greetings Members,


So this will be the FOURTH time I am alerting AXXE to you

They have retraced right below the levels when I last picked them and they look like they could rocket back up to the .24 - .25 levels again!

I am going to keep this report very short, as I am sure most of you are familiar with AXXE

Why do I like AXXE so much again?

Reason #1 Last Time I Picked AXXE around these levels they ran upwards to .245 shortly after
Reason #2 There is a short position on AXXE that if covered, could help with momentum
Reason #3 They have been releasing fantastic news




COMPANY PROFILE

Axxess Pharma: a focused health-care company dedicated to providing a wide range of products to improve the lives of patients and consumers worldwide

We believe action defines leadership

Our 23 wholly-owned prescription and non-prescription products are targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more. Axxess Pharma intends to market these products with affordable pricing and widespread availability. Our company will continue to tap the well of innovation to develop ever-more effective and affordable treatment options for the patients we serve, and also foster innovation in education, leadership and advocacy

Personal passion concerning the well-being of chronic illness sufferers is a major driving force and at the heart of our company. Affordable, proven, prescription and non-prescription products are a critical component to our company Business Plan. We balance environmental impact, social contribution, and financial results. Axxess Pharma is publicly traded on the US stock exchange under the ticker symbol: AXXE

AXXE Released Positive News October 6th 2014


Axxess Pharma Reports Continued Sales Growth From US Military,
Through Social Media and Celebrity Sponsorships -- Launches
TapouT Turbo Blend Protein Powder and
High-Potency Omega-3 Fish Oil

TORONTO, ON--(Marketwired - Oct 6, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., that they are continuing to experience increased sales of their Tapout Muscle Recovery line and expect the increase in sales to accelerate with the launch of the new TapouT Turbo Blend Protein Powder product and Omega-3 Fish Oil.
The increase in sales was fueled by a rise and frequency in US Military (AAFES) orders, added retailers, effective social media advertising and celebrity sponsorships

In anticipation of the rise in demand, Axxess Pharma has increased paid for wholesale inventory to approximately $1 m

Axxess Pharmas unique protein powder known as The TapouT Turbo Blend Protein Powder, received extremely positive feedback at the Mr. Olympia show from the public as well as industry professionals. The TapouT Turbo Blend distinguishes itself from the competition with several innovations such as an organic sourced-whey blend, gluten-free, added L-carnitine (fat-burner even at rest), added iron and fish oil

Within the last 60 days, Axxess Pharma has experienced strong growth on Facebook, Twitter and Instagram. Axxess Pharma also received strong interest at last week's Mr. Olympia event in Las Vegas. The company's sponsors, Ryan Jimmo and Catia James were at the event. Following the event, Axxess Pharmas social media traffic increased to new highs. In addition to the Mr. Olympia event, Axxess Pharma will continue to receive more attention at the upcoming NASCAR race with Cole Whitt and BK Racing in November. These and other marketing initiatives are helping to drive engagement and traffic from the social channels and converting that traffic into sales

Dr. Bagi, President of Axxess Pharma stated: "We have increased inventory of our TapouT line of products including the new TapouT Turbo Protein Powder and Omege-3 Fish Oil. The sharp rise in inventory was due to the Army Air Force Exchange increasing the volume and rate of orders, and our addition of new retailers in the short term. Since all our inventory is paid for, we are now focussing our resources on increasing marketing efforts through spokespersons and social media campaigns, as these efforts have contributed to our growth in sales."

Scott Debson, Managing Partner of SA Studios Global stated. "TapouT is recognized as a leader in the MMA sector. We are very pleased to see strong results from our social media efforts. These efforts have generated increased online sales. " Mr. Debson further stated, "Our social media efforts comprises the TapouT Muscle Recovery Team (TMR), of Brittney Palmer, Tyron Woodley, Catia James, Ryan Jimmo, Cole Whitt, Matthew Barnaby, Stephen Downes and Dr. Michelle Basu Roy. All of these sponsors are helping propel TMR's social media reach and popularity, thus strengthening the brand in the most organic way possible."

Who Is Leading AXXE?

I Know It's Boring, But It Makes Me Tingle
To See The Brains Behind This Operation


Management

Daniel Bagi, M.D., President

Daniel Bagi, M.D. is a senior executive physician with 20+ year’s international experience in the medical device/pharmaceutical industry, with an emphasis on Product Development, Business Development and licensing. Expertise in product development as it pertains to clinical development for commercial use; medical affairs and clinical research, specifically oncology and gynecologic topical women’s health products. Good knowledge of international regulatory standards. Secured numerous license deals internationally, between North American pharma companies and local partners. Extensive experience presenting to financial institutions, regulatory agencies, and potential pharmaceutical partners

Stephen Taylor, Investor/Business Relations

Stephen Taylor CEO/Pres. of Taylor Capitol, Inc., has provided Investor Relation services for 12 years with a prior background in equity research and investment banking in the Wall Street area. Stephen Taylor possesses a deep network of connections in the investment community. This network ranges from retail brokers, fund managers, wealth managers, Wall Street analysts, investment bankers, private equity firms and senior level management consultants

Neil Mellor, Senior VP Sales & Operations Canada

Neil Mellor has over 25 years of pharmaceutical experience both in Canada and in Europe. Neil has worked for large companies such as Merck, GSK and Pfizer and has also worked with medium-sized pharma companies such as Solvay Pharma. Neil has spent the majority of his background in sales, marketing and business development and has been involved with over thirty products in numerous therapeutic areas. Neil brings a great deal of first-hand experience in commercializing products. In addition, during 2008 Neil was President of the Canadian Healthcare Licensing Association (CHLA) and currently serves as a CHLA Board member. Neil is currently President of Global Health Link Corp. which is a consulting company serving the needs of large and small pharmaceutical companies in Canada and the US

Dr. Fred Maese, Senior Consultant of Medical Affairs

Dr. Maese is Board Certified Cardiologist and a member of the American College of Cardiology. Dr Maese performed his specialtly training in Internal Medicine and Cardiology Fellowship at Baylor College of Medicine in Houston, Texas. Since 1997 he has been practicing adult Cardiology and Internal Medicine in Dallas, Texas. Dr. Maese has expertise in general clinical cardiology, echocardiography and nuclear cardiology

Dr. Maese was instrumental in the clinical acceptance, widespread use and business models pertaining to the Lap Band procedure for bariatric patients with and without cardiovascular disease who had failed conservative medical weight management. Dr. Maese also has significant experience in medical education in both radio and television, with his segment "Break through Medicine" receiving an overwhelming acceptance by the public and peers on the popular show Good Morning Texas. In addition, his radio shows on Univison in Texas have also focused on an educational format pertinent to the Latin American population. This year he will launch both English and Spanish weekly radio programming on a variety of medical and political topics

Dr. Maese is also the creator of the MyClinic affordable and convenient primary care model, started in 2011 and now in the expansion phase. This concept of primary care delivery services promotes preventive, acute and chronic care strategies for the whole family in an affordable and convenient fashion. MyClinic is poised to become a leader in the primary and preventive care services for the population over the next three to five years



5 Reasons To Pull Up AXXE NOW



Reason #1

AXXE has seen spurts of action throughout the last few months, a combination of all this new information could shoot them forward

Reason #2

AXXE has released Multiple impressive press releases

Reason #3

AXXE is a Small player in a Big industry

Reason #4

AXXE is small-cap company with the potential to show Big Swings


Reason #5

AXXE has an experienced team that is looking out for the companies/shareholders best interests


Start your own research and due diligence now

Don't waste another moment


Sincerely,

Research Driven Alerts
































As always do your own research on all profiles that I give. Penny stocks are risky, like most speculative investments. Always view the company websites and base your own opinion.














GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY

http://www.growingstocksreport.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “RDI” or “we” or “us” or “our”). RDI publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. RDI does not undertake any due diligence or investigation of the Information it obtains or publishes. You should not consider the Information published by RDI to be a true, accurate, complete or reliable. The Profiled Companies actual results and financial condition may differ materially and be completely different than that published or described in the Information. The Information is not an offer or solicitation to buy or sell securities of the Profiled Companies. You should not consider the Information to be a recommendation or indication as to when you should buy or sell securities or if you should buy or sell securities of the Profiled Companies. RDI and its officers, directors, owners and employees are not licensed as brokers, broker dealers, market makers, investment bankers, investment advisors, analysts or underwriters. You should not consider the Information when making an investment decision of whether to buy or sell securities of any Profiled Company on RDI and you should consult with and request that your investment advisor or attorney verify any information you rely upon in making an investment decision. You should consult your financial and legal advisers before purchasing or selling the securities of any Profiled Company. Affiliates, officers, directors and employees of RDI may own or may purchase shares of the Profiled Companies and may sell their securities at times when RDI publishes Information on the Profiled Company including when investors purchase the securities of the Profiled Companies.

RDI will not advise you prior to buying or selling the securities of the Profiled Companies does not and the Information should not be considered when making a decision to buy or sell securities of the Profiled Companies. The Information is not a solicitation or recommendation to buy, sell or hold securities and does not provide reliable information or analysis of the financial position of the Profiled Companies. All statements in the Information are subject to change without notice and are not reliable. RDI is not liable for any investment decisions by its readers. Readers should independently investigate and fully understand all risks before investing in any Profiled Company.

The owners, associates, officers, directors and/or employees and/or principals of RDI may have stock positions in the Profiled Companies obtained from purchases in the open market or in private transactions. RDI will liquidate any securities of the Profiled Companies at its discretion without notification to any party including you even it has made published positive Information about a Profiled Company. By reviewing RDI’s website you accept these terms and conditions.

Any investment in the Profiled Companies involves a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results.

The information contained herein contains “forward-looking statements,” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified thorough the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in public information including but not limited to reports filed with the Securities and Exchange Commission and/or OTC Markets. You may obtained information about some of the Profiled Companies from the OTC Markets Website at www.otcmarkets.com or from the website of the Securities and Exchange Commission, at www.sec.gov without charge.

Buying and Selling of Shares
RDI may sell any shares of the Profiled Companies for less than target prices set forth in the Information and may profit by selling their securities while investors are purchasing during the same time RDI publishes the Information.

The securities of the Profiled Companies are high risk, unstable, unpredictable and illiquid. The securities of the Profiled Companies are considered in most circumstances to be penny stocks and should not be purchased by anyone who cannot sustain a complete loss of their investment. . If you cannot sustain the loss of your entire investment you should not purchase securities of the Profiled Companies. If at anytime you wish to be removed from our list simply unsubscribe in any of the previous emails sent to you.

17(B) Disclaimer
http://www.growingstocksreport.com/ is owned and operated by Research Driven Investor, LLC which is an American corporation.

RDI electronically disseminates information on its website, in newsletters, featured reports, spam compliant double-opt in email communications or otherwise pertaining to Profiled Companies’ the securities of which are most frequently penny stocks and common stock quoted on the OTCQB or Pink Sheets.

Because RDI receives compensation for RDI’s dissemination of the Information (as disclosed in our Compensation Disclosure Section), including at times in the form of common stock shares (the “Shares”), RDI should not be considered to be independent or objective and the Information may enable RDI to publicly sell its shares when it would have otherwise been unable to do so.

RDI does not perform research, due diligence or undertake an analysis of the Profiled Companies. RDI does not endorse, independently verify or assert the truthfulness, completeness, accuracy or reliability of the Information and conducts no due diligence whatsoever of the Profiled Companies. Your use of the Information is at your own risk. RDI disclaims, expressly and impliedly, all warranties of any kind, including whether the Information is accurate or reliable or free of errors. By reading the Information, you hereby agree to indemnify and hold RDI harmless from any liability for any claimed direct, indirect, incidental, punitive, or consequential damages pertaining to the Information.

The Information is presented only as a brief “snapshot” of the Profiled Company and should only be used, at most, and if at all, as a method of obtaining the names of penny stocks and a starting point for you to conduct a thorough investigation of the Profiled Company and its securities and to consult your financial, legal or other advisor(s) and avail yourself to the filings and information that may be accessed at www.sec.gov . or www.pinksheets.com or other electronic medium, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets; (c) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (e) consulting investment guides at www.sec.gov and www.finra.com pertaining to the risks of investing in penny stocks. Readers must evaluate and bear all the risks associated with the Information, including reliance on its accuracy, completeness or usefulness. In all instances, you should conduct due diligence and its own review of the Profiled Companies and its securities.

The Profiled Companies are subject to possible risks, including but not limited to: (a) the Information pertains to penny stocks that are subject to the SEC’s penny stock rules and commonly involve a high degree of risk that may result in the loss of some or all of an investment in the Profiled Company’s securities; (b) the Profiled Company’s penny stock may be thinly traded, which may lead to difficulties of selling its securities; (c) a Profiled Company that is an SEC reporting issuer who is a Profiled Company may be delinquent (not current) in its periodic reporting obligations (i.e., in its quarterly and annual reports) or the Pink Sheet quoted company may be delinquent in its Pink Sheet reporting obligations as indicated by Pink Sheets New Service’s posting a negative “sign” pertaining to the Profiled Company at www.pinksheets.com , as follows: (i) “Limited Information” for companies with financial reporting problems, economic distress, or that are unwilling to file required reports with the Pink Sheets; (ii) “Pink Sheets – No Information”, which indicates companies that are unable or unwilling to provide disclosure to the public markets, to the SEC or the Pink Sheets; and (iii) “Caveat Emptor”, signifying “Buyer Beware” that there is a public interest concern associated with a company’s illegal spam campaign, questionable stock promotion, known investigation of a company’s fraudulent activity or its insiders, regulatory suspensions or disruptive corporate actions; (d) whether the Profiled Company is a development stage company with little or no operations, the securities of which should be considered extremely speculative for investment purposes; (e) RDI‘s selling of an Profiled Company’s securities may cause its stock price to significantly decli ne, especially when such securities are thinly traded; (f) many companies that have their securities quoted on the OTCBB or Pink Sheets (as well as even Exchange listed companies) have been negatively affected by the current economic downturn and lack of adequate financing to meet their operational goals or expansion plans; (g) any percentage gain from the previous day close presented on our website at is not and should not be construed as any indication whatsoever of the future stock price of an Profiled Company’s securities or its operational results; (h) many of the energy related and other Profiled Companies are subject to increasing environmental and other governmental regulations, which subjects them to significant costs and possible fines and liabilities for failure to comply with applicable state and federal statutes; (i) RDI may receive compensation in shares of the Profiled Company and it or its associates, affiliated entities, officers, directors or immediate family members may sell the Shares immediately upon their receipt as well as during the dissemination of such Information or within hours, days, weeks or months thereafter, or at any time; as a result, RDI’s selling activities may cause significant volatility in the Profiled Company’s stock price and/or significantly depress the Profiled Company’s stock price; (j) RDI may buy and sell the Shares in the open market before, during or after the dissemination of the Information or at any time, which may cause significant volatility including drops in the price of the Profiled Company’s stock price and/or significantly depress the Profiled Company’s stock price; (k) future success of many OTCQB and Pink Sheet quoted companies is dependent upon receiving adequate financing or raising sufficient capital, which they may be unable to obtain; (l) there is an inherent and actual conflict of interest that exists between our Readers’ interests and RDI’s interests because RDI’s owners, RDI: (i) receive the Shares as compensation for disseminating the Information and thereafter sell those Shares at any time for monetary gain, including at the same time the Information is being disseminated or shortly thereafter or at any time; and (ii) buys and sells the Profiled Company’s shares in the open market at the same time or before the Information is being disseminated or shortly after the dissemination of the Information or at any time; (m) we do not receive any direct verification from the Profiled Company regarding the Information; (n) a third party shareholder may have a potential or actual conflict of interest in paying RDI for the dissemination of the publication while still holding the Profiled Company’s shares of common stock that he or she may sell after the third party shareholder has paid RDI with his or her shares; (o) the Information should not be interpreted in any shape, form or manner whatsoever as an indication of the Profiled Company’s future stock price or future financial performance since, among other reasons, such “comparison” companies are listed on Exchanges (i.e., the New York Stock Exchange) and trade at stock prices that are thousands of percent higher than the companies we profile; and (p) Readers may encounter difficulties determining what information contained in our publications is material or non-material making it all the more imperative that they conduct further investigation of the Profiled Company and its securities ; and (q) RDI may hire third party service providers and stock promoters to electronically disseminate live news regarding the Profiled Company, information which we do not independently provide to the Service Provider or verify and upon which we have no control over. We pay cash consideration to the Service Providers; no securities compensation is paid to the Service Providers; and (r) our employees post messages on their individual message boards as a method of disseminating the Information on behalf of the Profiled Companies which should never be used as a means of conducting analysis into the Profiled Company and should only be used as a starting point to obtain the names of pink sheet or OTCQB companies. Research Driven Alerts aka research driven investor llc was not compensated to profile AXXE for two days starting 08/10/14 and owns zero shares in AXXE. Previously Research Driven Alerts aka research driven investor llc received the following compensation for this publication:Eighteen Thousand dollars in cash paid directly to RDI aka research driven investor llc, by The Stock Alerts LLC , a non affiliated third party to profile AXXE for a two day investor relations campaign. Zero in restricted or free common shares paid directly to RDI aka research driven investor llc. Previously Research Driven Alerts aka research driven investor llc received the following compensation for this publication:Twenty Five Thousand dollars in cash paid directly to RDI aka research driven investor llc, by The Stock Alerts LLC , a non affiliated third party to profile AXXE for a two day investor relations campaign. Zero in restricted or free common shares paid directly to RDI aka research driven investor llc. Previously RDI aka research driven investor llc received the following compensation for this publication: Thirty thousand dollars in cash paid directly to Research Driven Alerts aka research driven investor llc, by The Stock Alerts LLC,a non affiliated third party to profile AXXE for a two day investor relations campaign. Zero in restricted or free common shares paid directly to Research Driven Alerts aka research driven investor llc. Thirty thousand dollars in cash paid to Research Driven Alerts aka research driven investor llc, an American corporation controlled by research driven investor llc. To date RDI aka research driven investor llc has received seventy three thousand dollars in cash to profile AXXE, by The Stock Alerts LLC, a non affliated third party.To view our full disclaimer go here: http://www.growingstockreport.com/Disclaimers.aspx


*Our main link to our disclaimer for RDA is having issues and will be resolved by 09/30/14. In the meanwhile we have added a disclaimer from growing stock report link for disclaimer to remain legally transparent. Growing Stock Report is a sister company to RDA. And both of these companies are owned by research driven investor LLC.

Please turn your full attention to NGMC (Next Generation Management Corp.).

NGMC is operating in a market that has been quite friendly to us before.

Through its wholly-owned subsidiary, this true 1 cent alert provides dispensary and grower management services to the medical cannabis industry including staffing, information technology, security, financial, and advisory services.

The medical cannabis sector as a whole has been extremely bullish this year, and investors have made small fortunes trading high growth opportunity companies like NGMC.

Right now, Medical Cannabis stocks are the closest we have seen to a sure thing on Wall St. in a long long time.

Our last pick in this sector, MDEX, netted traders over 42% in real possible gains just over a week ago.

If NGMC performs the way we believe it can, we have no doubt it will dwarf the gains that MDEX showed us.

Our confidence is high on NGMC for a number of reasons.

The company is in the midst of an aggressive growth strategy.

Just a few weeks ago, NGMC announced that their wholly owned subsidiary NextGen Cannabis Consulting LLC, entered into an agreement with the Shevin and Clark Consulting Firm to expand operations into the State of Oregon. NGMC will initially apply for 3 dispensary licenses while identifying key retail locations.

NextGen Cannabis Consulting LLC recently opened and is operating its first of several medical cannabis dispensaries in Los Angeles for its initial client, H2H.

"We are now ready to begin executing on our plan to expand operations in all states that have legalized medical cannabis. We are very enthusiastic about the opportunities in Oregon, which will be our next focus," said Darryl Reed, CEO of Next Generation Management Corporation.

"Shevin and Clark provide comprehensive business strategies and legal counsel in the cannabis industry. They bring extensive of knowledge in the Oregon medical cannabis marketplace and will help our Company considerably reduce its time to market," Mr. Reed stressed.

Historically growth and expansion have been one of the biggest driving forces behind share price, and news of this expansion into Oregon could have NGMC's share price moving upward in no time.

The Oregon expansion could be just start to even bigger and better things for NGMC.

So far, 23 U.S. states and Washington D.C. have legalized medical MJ, while Colorado and Washington State have legalized recreational MJ.

These trends are set to continue in the November in the general election with several outstanding ballot measures already in place.

With legalization bills currently taking form in both the House and Senate, it's only a matter of time before cannabis based companies like NGMC lock down the market.

The U.S. cannabis industry grew 64% in 2013, and is expected to reach $2.34 billion by the end of 2014, according to ArcView Market Research.

From a technical standpoint NGMC appears to be one of those highly desirable low/risk high reward opportunities.

NGMC is a true 1 cent gem, and with its low float of 159M the breakout potential is enormous.

We've already watched it explode for +1,200% in just one trading session earlier this year, and it has a long history of price rallies of +100% and higher.

Strong support seems to have established at these current levels, and volume has picked up substantially over the past few days.

The stock appears to be oversold at the moment, and traders who pick up shares now could see huge profits in the very near future.

All the indicators are telling us the the next +100% rally is just about to start, and we want everyone on board.

We were looking for a perfect low risk/ high reward opportunity for our 'redemption pick', and NGMC fits the bill to a tee.

With big news expected to be dropped as early as tomorrow morning, we are anticipating a long and steady uptrend for NGMC in the days to come.

We are urging all of our members to have NGMC up on their trading screens tomorrow morning at 9:30am EST, and to be ready to ready to take action!

Please review NGMC's Company Profile, 1-Year Chart and most recent News Release below:


-------------------------------------
Company: Next Generation Management Corp.

Ticker: NGMC

Current PPS: $0.012

Float: 159M

Website: www.nextgenmanagementcorp.com
-------------------------------------
Next Generation Management Corp. (NGMC) focuses, primarily, on the acquisition of retail and cultivation licenses in the medical cannabis industry.

The Company’s overarching strategy is to acquire lines of business that have high intrinsic future value and to generate existing, reliable revenue streams, with the medical cannabis industry being its most recent and promising direction. With this expanded direction, the Company has formed a wholly owned subsidiary, NextGen Cannabis Consulting LLC to provide management services to the high growth, high profit medical cannabis industry. NextGen Cannabis Consulting is intent on the development of a national brand that encompasses every aspect of the medical cannabis industry, including collectives, dispensaries, and grow-ops.

NextGen Cannabis Consulting, a wholly owned subsidiary of NGMC, currently has 1 dispensary open in North Hollywood, Los Angeles, CA, a consulting agreement with a grow-op in CA, a retainer agreement with an attorney in CA, and an expanding operation into the state of Oregon.

The company also provides dispensary management services to the medical cannabis industry including staffing, IT, security, financial, legal and advisory services.

hey have partnered with software company BioTrackTHC that allows for a seed to sale solution with grow house/plant management, inventory management, customizable point of sale functionality and a feature rich suite of state and local regulatory agency compliance reporting.

Market:
The cannabinoid market is estimated to total $30-$50 billion however, based on the Federal Medical Cannabis Program internal estimates believe the market will actually be worth $74 billion in 2017.
Cannabinoids have been found to aid migraine headaches, insomnia, depression, epileptic seizures, chronic heartburn, AIDS/HIV, Alzheimers, Asthma, Autoimmune Disease, Cancer, Crohn’s Disease, Diabetes, Digestive Disover, Gastro Intestinal (GERD), Glaucoma, High Blood Pressure, Influenza, Multiple Sclerosis, Pain Management, and Tourette Syndrome
The U.S House and Senate is currently aiming to change the medical cannabis laws
The New York Times recently released an article comparing the medical cannabis market as the new “repealing prohibition” era.
According to ArcView Market Research, the U.S Cannabis Industry increased 64% in 2013, is expected to total $2.34 billion by the end of 2014, and increase to $10.2 billion by 2019.
In April 2014, the MJ Business Daily predicted that U.S retail cannabis sales has the potential to total $7.4 - $8.2 billion by 2018.
In 2013, over $1.43 billion worth of legal cannabis was sold between medical cannabis retailers, processors, and dispensaries and is expected to increase 64% to $2.34 billion by 2014
Colorado shop owners estimate they generated over $1 million in collective sales on the first day of legalization.
The state of Colorado also expects tax revenue of cannabis sales to total $91 million.
Colorado estimates the industry could generate the state $600 million in revenues for 2014.
Sales in the state of Washington have exceeded $10 million however the supply is not meeting the demand.
A recent article by CNBC details “How legal cannabis could be the next great American industry.”
Recent News:

NextGen Cannabis Consulting, A Next Generation Management Corp. Subsidiary, Announces Expansion Plan In Oregon
NextGen Cannabis Consulting, A Next Generation Management Corporation Subsidiary, Retained to Assist Medical Marijuana Growing Operation
Next Generation Management Corp. opens medical marijuana dispensary in Hollywood

If you're looking for a very desirable low risk/high reward opportunity in a booming sector, then please look no further.

NGMC is on high alert for tomorrow, and we want all of our members to have it up on their trading screens tomorrow at 9:30am EST

Let's get ready for an exciting day of trading.

Best Regards,

PennyStockLocks Team

P.S.

* Share the wealth by forwarding this email to your friends & family who have yet to join the fastest growing network of successful traders on the web!

Remember, the first step to becoming a successful penny stock trader is opening up a trading account at a reputable online brokerage, so if you haven't done so already, you can start by clicking here!



NextGen Cannabis Consulting, A Next Generation Management Corp. Subsidiary, Announces Expansion Plan In Oregon
-- Oregon Presents Great Opportunities --
PR Newswire Next Generation Management Corporation
September 8, 2014 8:41 AM

FAIRFAX, Va., Sept. 8, 2014 /PRNewswire/ -- Next Generation Management Corp. (NGMC) announced today its wholly owned subsidiary, NextGen Cannabis Consulting LLC, has entered into an agreement with the Shevin and Clark Consulting Firm to expand operations into the State of Oregon. NGMC will initially apply for 3 dispensary licenses while identifying key retail locations.

NextGen Cannabis Consulting LLC recently opened and is operating its first of several medical cannabis dispensaries in Los Angeles for its initial client, H2H.

"We are now ready to begin executing on our plan to expand operations in all states that have legalized medical cannabis. We are very enthusiastic about the opportunities in Oregon, which will be our next focus," said Darryl Reed, CEO of Next Generation Management Corporation.

"Shevin and Clark provide comprehensive business strategies and legal counsel in the cannabis industry. They bring extensive of knowledge in the Oregon medical cannabis marketplace and will help our Company considerably reduce its time to market," Mr. Reed stressed.

About Nextgen Cannabis Consulting LLC:
Next Generation Management Corporation's wholly-owned subsidiary provides dispensary and grower management services to the medical cannabis industry including staffing, information technology, security, financial, and advisory services.

Contact: Paul Knopick
pknopick@eandecommunications.com
940.262.3584
Disclaimer:

PennyStockLocks LLC has been compensated $5,000.00 on 10-09-2014 for the awareness of NGMC from a third party Mantle Media LLC.

What do YTRV and MNGG have in common? Shows: Yatura Ventures Corp (the "Company") is an Nevada Corporation which was incorporated on November 20, 2006. There
are no known predecessor entities in the past five years at this time.

when I looked at the OTC info - http://www.otcmarkets.com/stock/MNGG/filings

Yet another one - this one is primed pumped and ready to go tomorrow.



Today's Profile Is: MDEX


Hi All,



Did you miss our announcement yesterday which saw GAINS OF 200% in UNDER one hour?

We're sorry if you did but we have another amazing stock for you to get on your watch list tonight that could offer some pretty EXPLOSIVE RETURNS in the near term!

Hury and start your research!

Our announcement tonight is on: MDEX

MDEX is a technology company positioned to become the leading smokeless cannabinoid technology provider!

One of the HOTTEST segments in the market is the marijuana industry!

Marijuana stocks have been on fire this year and investors have been going through the market with a fine tooth comb looking for what could be the next Microsoft or Apple in the sector.

At these levels MDEX could be a huge opportunity and the company may soon be one of the leaders in the legal marijuana arena!

Cannabinoid Therapy:

Many of you may already know what a cannabinoid is. They are contained in marijuana.

There are a number of specific cannabinoids contained in marijuana and these cannabinoids have been found useful in the treatment and prophylaxis of a wide variety of oxidation associated diseases.

This includes: cataracts, sleep disorders, seizures and autoimmune diseases.

The cannabinoids are also believed to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic invectives, such as stroke and trauma, or in the treatment of neurodegenerative diseases including: Alzheimer's disease, Parkinson's disease and HIV dementia.

The ability to separate the cannabinoids from the psychoactive THC can allow therapy free of the effects of THC.

As THC enters the brain, it causes the user to feel euphoric. In other words, high.

There are many people who want the benefits of marijuana WITHOUT the high!!

Separating cannabinoids from THC is particularly advantageous in therapies involving children.

So why is MDEX so attractive to us?

The company has been able to separate specific cannabinoids and integrate them into their product called CannaStrips!

CannaStrips:

MDEX has a proprietary technology called "CannaStrips."

This is in advanced development of a number of additional smokeless delivery systems designed specifically for smokeless cannabinoid therapy.

The CannaStrips technology was developed over four years of formulation and testing. The results of those efforts encompass four smokeless cannabinoid delivery technologies, oral strips, vapor oils, mist spray and droplets.

MDEX intends to license the CannaStrips technology, which will include proprietary equipment being leased to CannaStrip's licensees that have State approved marijuana production facilities and/or dispensaries.

The company plans to focus initially on: California, Colorado, and Washington State.

Both Colorado and Washington State allow marijuana recreationally legally!

The market potential in these two states could be astronomical!

MDEX CEO Brent Inzer commented: "The ability to deliver cannabinoid therapy specific to a patients exact needs greatly increases the possibility for monitoring the effectiveness of the therapy and hopefully promoting clinical trails and further in depth cannabinoid studies and testing."

Brent Inzer:

Another huge reason why MDEX could be very opportunistic is because of having Brent Inzer as CEO.

Inzer's past success could quickly push the company to the top!

In 2008 he was co-founder of Marijuana Medicine Evaluation Centers (M.M.E.C.) which in 2 years expanded into 14 standalone clinics.

M.M.E.C was the second largest provider of medicinal marijuana evaluations in the country with annual sales of over $6 million!

In 2010 General Cannabis, Inc., a publicly traded company, acquired another Inzer Company, Synergistic Resources. Mr. Inzer continued on with General Cannabis as a consultant.

During his time with General Cannabis Inc the company grew from $500,000 in annual sales to over 20 million dollars in annual sales in 2012!!

Could he quickly get MDEX to multi-million dollars in annual sales?

The company has already begun discussions with several licensed marijuana facilities and has received strong interest.

What MDEX is up to is all still very fresh which means these could be GROUND-FLOOR trading prices!

It was just this past June that MDEX announced the signing of an Agreement closing the acquisition of "CannaStrips."

As more of Wall Street finds out what MDEX is up to, levels could head higher!

This stock could be in for some amazing action soon so hurry and get it on your watch list right away.

Start your due diligence right away at: http://cannabinoidstrips.com

We are issuing a VERY STRONG ALERT on MDEX at these levels!



Sincerely,

StockFreak.com


GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY

We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Stockfreak.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Stockfreak.com or an offer or solicitation to buy or sell any securities.

None of the owners of Stockfreak.com , or any of its members, officers, directors, contractors or employees is a licensed broker-dealer, account representative, market maker, investment banker, investment advisor, analyst or underwriter. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Stockfreak.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.

Stockfreak.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Stockfreak.com has no obligation to update any of the information provided, nor is it responsible for errors and omissions.

From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our releases or on our website may not have approved certain or any statements within the release or website. Stockfreak.com encourages viewers to supplement the information obtained from any release or our website with independent research and other professional advice. By accessing, viewing, or using our website or communications originating from our website or any release therein, you agree that Stockfreak.com , its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Stockfreak.com , its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

Stockfreak.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold Stockfreak.com , its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. Stockfreak.com disclaims all warranties of any kind, express or implied. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or then FINRA at: www.finra.org . In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/investors/index.htm.

Questions regarding any information contained in this website may be sent to stockfreak.com To review our complete disclaimer and additional information, please visit stockfreak.com

COMPANY SPECIFIC DISCLAIMER

Some of the content in this release may contain forward-looking information within the meaning of Section 27 A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the profiled companies and the value of their securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. The company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned in our releases. A company's past performance does not guarantee future results. Further specific financial information, filings and disclosures as well as general investor information about the profiled companies, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org.

The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. This release may provide hyperlinks to third party websites or access to third party content. Stockfreak.com , its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Stockfreak.com control, endorse, or guarantee any content found in such sites.

Stockfreak.com was paid a total $22,000.00 in cash compensation from Microcap Innovations the 1 day profile of Madison Explorations (OTCBB:MDEX) services include the issuance of this release and other opinions that we release concerning of Madison Explorations (OTCBB:MDEX) Stockfreak.com has not investigated the background of Microcap Innovations, the hiring party, or Anyone viewing this newsletter should assume Microcap Innovations or affiliates of Microcap Innovations own shares of. Madison Explorations (OTCBB:MDEX) of which they plan to liquidate, and further understand that the liquidation of those shares may or may not negatively impact the share price. Stockfreak.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Madison Explorations (OTCBB:MDEX)

RECEIVED IN MY EMAIL TODAY! 4:31pm

Tomorrow's Alert Is MDEX!



Good Evening Traders!!

If you missed yesterday's alert, hurry and add this stock to your radar!

At these levels MDEX looks super attractive to us and we see a lot of potentia upside right now!

With the marijuana industry so huge right now, we are always on the hunt for what could be the next big leader in the arena. MDEX is up to something that could quickly push them to the frontline! The best part is that its all still fairly recent which means the levels right now could be GROUND-FLOOR!

About the Company:

It was just this past summer that MDEX announced the signing of an Agreement closing the acquisition of a smokeless cannabinoid delivery technology commercially known as "CannaStrips."

CannaStrips is in advanced development of a number of additional smokeless delivery systems designed specifically for smokeless cannabinoid therapy.

The technology was developed over four years of formulation and testing. The results of those efforts encompass four smokeless cannabinoid delivery technologies -- oral strips, vapor oils, mist spray and droplets.

MDEX intends to license the CannaStrips technology, which will include proprietary equipment being leased to CannaStrip's licensees that have State approved marijuana production facilities and/or dispensaries.

The company plans to focus initially on: California, Colorado, and Washington State. Both Colorado and Washington State started allowing recreational marijuana legally this year. The market is enormous! Recent state estimates have revealed that Washington can expect $637 million in revenue by 2019, while Colorado can expect $174.5 million through the fiscal year that ends in 2017.


Cannabinoid Therapy:

There are a number of specific cannabinoids contained in marijuana and these cannabinoids have been found useful in the treatment and prophylaxis of a wide variety of oxidation associated diseases.

This includes: cataracts, sleep disorders, seizures and autoimmune diseases.

The cannabinoids are also believed to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic invectives, such as stroke and trauma, or in the treatment of neurodegenerative diseases including: Alzheimer's disease, Parkinson's disease and HIV dementia.

The ability to separate the cannabinoids from the psychoactive THC can allow therapy free of the effects of THC.

As THC enters the brain, it causes the user to feel euphoric. In other words, high.

There are many people who want the benefits of marijuana WITHOUT the high!!

This is what makes MDEX so attractive to us.

The company has been able to separate specific cannabinoids and integrate them into their CannaStrips!

MDEX CEO Brent Inzer commented: "The ability to deliver cannabinoid therapy specific to a patients exact needs greatly increases the possibility for monitoring the effectiveness of the therapy and hopefully promoting clinical trails and further in depth cannabinoid studies and testing."

Brent Inzer:
Inzer's past success could quickly push MDEX to the top! In 2008 he was co-founder of Marijuana Medicine Evaluation Centers (M.M.E.C.) which in 2 years expanded into 14 standalone clinics.

M.M.E.C was the second largest provider of medicinal marijuana evaluations in the country with annual sales of over $6 million! In 2010 General Cannabis, Inc., a publicly traded company, acquired another Inzer Company, Synergistic Resources. Mr. Inzer continued on with General Cannabis as a consultant.

During his time with General Cannabis Inc the company grew from $500,000 in annual sales to over 20 million dollars in annual sales in 2012!!

Could he quickly get MDEX to multi-million dollars in annual sales? Hurry and start your research at: http://cannabinoidstrips.com

MDEX could be our next announcement to see gains of 100% or higher!


Good Luck!

-JPS





GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLYWe are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. JuicyPennyStocks.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by JuicyPennyStocks.com or an offer or solicitation to buy or sell any securities.None of the owners of JuicyPennyStocks.com , or any of its members, officers, directors, contractors or employees is a licensed broker-dealer, account representative, market maker, investment banker, investment advisor, analyst or underwriter. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. JuicyPennyStocks.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.JuicyPennyStocks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and JuicyPennyStocks.com has no obligation to update any of the information provided, nor is it responsible for errors and omissions.From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our releases or on our website may not have approved certain or any statements within the release or website. JuicyPennyStocks.com encourages viewers to supplement the information obtained from any release or our website with independent research and other professional advice. By accessing, viewing, or using our website or communications originating from our website or any release therein, you agree that JuicyPennyStocks.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that JuicyPennyStocks.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.JuicyPennyStocks.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold JuicyPennyStocks.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. JuicyPennyStocks.com disclaims all warranties of any kind, express or implied. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or then FINRA at: www.finra.org . In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/investors/index.htm. Questions regarding any information contained in this website may be sent to support@juicypennystocks.com To review our complete disclaimer and additional information, please visit juicypennystocks.comSome of the content in this release may contain forward-looking information within the meaning of Section 27 A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the profiled companies and the value of their securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. The company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned in our releases. A company's past performance does not guarantee future results. Further specific financial information, filings and disclosures as well as general investor information about the profiled companies, advice to investors and other investor resources are available at the Securities and Exchange Commission ("SEC") website www.sec.gov and the Financial Industry Regulatory Authority ("FINRA") website at www.finra.org.The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. This release may provide hyperlinks to third party websites or access to third party content. JuicyPennyStocks.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does JuicyPennyStocks.com control, endorse, or guarantee any content found in such sites.&JuicyPennyStocks.com was paid $2,000 in cash compensation from Speak Easy Media, LLC (“Speak Easy Media, LLC”) for the 1 day profile of Madison Explorations Inc. (OTCBB:MDEX) (“Madison Explorations Inc.”) which services include the issuance of this release and other opinions that we release concerning of Madison Explorations Inc. JuicyPennyStocks.com has not investigated the background of Speak Easy Media, LLC, the hiring party, or Madison Explorations Inc. Anyone viewing this newsletter should assume Speak Easy Media, LLC or affiliates of Speak Easy Media, LLC own shares of Madison Explorations Inc. of which they plan to liquidate, and further understand that the liquidation of those shares may or may not negatively impact the share price. JuicyPennyStocks.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Madison Explorations Inc.

Will The Las Vegas Nevada Corporate Stock Buy Backs Keep The Stock Market Above 17,000 Is Reviewed By Ross Aldridge?

http://stockblogs.com/will-the-las-vegas-nevada-corporate-stock-buy-backs-keep-the-stock-market-above-17000-is-reviewed-by-ross-aldridge/

"Repurchases and buybacks soared nearly 60 percent in the first quarter, putting a floor under a market that struggled amid a brutal winter and an economy that contracted at least 1 percent. Companies have used bargain-basement interest rates to borrow money for stock purchases, which have fed the equity market even as gross domestic product growth has stumbled along."

So what you are saying is, Yes it can be done.

I cant find such a law either. Please share, I need evidence as proof when it comes to things like this, no offense to you at all.

ALSO

How do you explain this? Just another lie? "Since the arrival of the new management team in May of 2014, the Company began with more than $3 million in debt, as reported in its last 10-K, and has successfully lowered that amount to under $1 million, for a net reduction of more than $2 million worth of debt, as of August 19, 2014."

He can buy retail right?

He said buy backs not dilution

We'll if this is a pump and dump there is not much to dump here

What about the video and twitter updates. Seems to be reaching out to folks here. Selling gold and other businesses proposals of buy backs etc

Doesn't the SEC freeze known pump and dumps or scammers before people lose money. The reporters of the PR campaigns, do they review the news being provided as truthful?

I want to believe that the Ming story is truthful and find it very hard to believe the CEO would take such a risk to make up such a lie. It would be suicidal to blatantly lie and eventually would find himself behind bars I would hope. I said gold mine with exclamations didn't I, lol

I hope something happens here soon. Seems pretty stale at the moment

Great risk/reward here IMO. Throw down a few bucks and grab a seat to the show!

I bought shares of this company as a sleeper hold. This thing will pop someday IMO I just have to wait.

I personally would like to take the risk here, regardless of CEO history. What if this guy hits a "goldmine" here and we all get rich.

Form 8-K
Current Report
Filed Oct 3, 2014

http://ir.odysseymarine.com/secfiling.cfm?filingid=1193125-14-362418&CIK=798528

Just did it.

Now that would not be good, with the amount of money and trades going on here and the big names on board I think something big is happening here. Does Reloading the Pump make any sense?

Someone reach down and give me 5's I'm in at this bottom!

Odyssey Marine Exploration Implements Planned Management Transition

President Mark D. Gordon Appointed CEO, Greg Stemm Becomes Chairman as the Company Prepares for Several Monetization Events and Shipwreck Projects

TAMPA, Fla., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Odyssey Marine Exploration, Inc. (Nasdaq:OMEX), a pioneer in the field of deep-ocean exploration, has implemented its planned management transitions that were announced in August.

Odyssey President Mark D. Gordon assumed the additional role of chief executive officer on October 1, 2014, succeeding Gregory P. Stemm, who had held the position since 2007. Stemm has become chairman of the board, succeeding Bradford B. Baker, who will continue to serve as lead director. Stemm, in his new role, will continue to provide counsel to the company, focusing his efforts on identifying and developing new business opportunities for Odyssey.

"These management changes reflect the broader, ongoing transition of Odyssey from an entrepreneurial business model to a more predictable revenue-generating entity as well as our anticipation of new projects and monetization events ahead," commented Stemm. "We have long planned for Mark to take over as CEO, and there is no question that he is ideally suited to the role. Mark is an extraordinarily brilliant, capable and dedicated executive who I know will do great things for Odyssey."

"The board recognizes Greg's tremendous contributions to Odyssey since its inception and values his unique talents and visionary thinking," noted Baker. "With Mark as CEO, Greg has been freed from the day-to-day operations of the company, allowing him to fully focus on developing new opportunities in deep-ocean exploration for Odyssey. Given Mark's strong performance as president over the last several years, the board is highly confident that Mark and the team he has helped assemble will take Odyssey to its next level of growth and development."

As one of the company's founders, Stemm has served the company for more than 20 years. Under his leadership, Odyssey has become the preeminent and most widely recognized shipwreck exploration organization in the world. No other entity has found and recovered more valuables from the ocean floor and at such record depths.

As part of the planned transition, Gordon has been working closely with Stemm on initiatives that position the company for profitability, which include:

Moving the company from solely seeking high-value historical shipwrecks towards a more balanced model that includes commodity shipwrecks and mineral exploration.
Implementing increased financial discipline that resulted in outsourcing the exhibit business, discontinuing the long-term lease of the Discovery Dorado vessel, and developing financial modeling for all new projects. This discipline is projected to reduce expenses by 30%, improve asset utilization, and improve the risk/return profile on selected projects.
Increasing communication and transparency with stakeholders via quarterly conference calls, letters to shareholders, and an outreach to institutional investors.
Attracting new talent to the company including the CFO and a new independent board member with previous Wall Street investment banking experience.
These initiatives have helped Odyssey deliver multiple profitable projects over the past three years that demonstrate the basic business model can be successful.

In 2012 and 2013, the Gairsoppa project generated $79 million in cash proceeds of which $12 million went to the UK Government and the silver refiner, leaving $67 million for Odyssey. After direct project costs of $27 million, a project profit of $40 million was generated for a gross margin of 60%.
Since the inception of the Oceanica project, Odyssey has spent approximately $20 million in direct costs and received $27.5 million cash in exchange for a minority stake in Oceanica. Odyssey currently retains 54% of the equity in Oceanica which has tremendous potential to produce significant returns for Odyssey.
The 2014 Central America project, conducted between April and September of this year, is expected to generate a gross margin well in excess of 30%.
Gordon plans to continue the focus on deep-ocean exploration while implementing modifications to the existing business model that are designed to expand the demonstrated individual project profitability into enhanced overall operating results with more predictable positive financial results.

"Given my first-hand knowledge and understanding of Odyssey's strengths, capabilities and challenges, I believe we have a phenomenal opportunity to take our successful project model and make small modifications to our business to produce positive, more predictable operating cash flows for years to come," said Gordon. "These adjustments to our business model are designed to mitigate risk, enhance our cash generation, and continue to allow us to harvest our portfolio of valuable projects in a disciplined manner that continues to produce leveraged returns."

"As we begin the final quarter of 2014, we will focus on improving asset utilization and aligning our expenses and investments with defined opportunities that have demonstrative near-term return. We will continue to develop projects that build long-term shareholder value and build on our legacy of excellence in deep-ocean exploration," continued Gordon.

"In the coming months, we anticipate a number of key events, including further monetization of our Oceanica project, the start of one or more shipwreck projects, and monetization of the SS Central America recovery," continued Gordon. "I look forward to discussing our plans for 2015 in more detail during our upcoming quarterly conference call in November."

Gordon joined Odyssey in 2005, serving as director of business development and executive vice president of sales before he was appointed president and chief operating officer in 2007 and director in 2008. Prior to Odyssey, Gordon founded or managed four entrepreneurial ventures from 1987 to 2003, including Synergy Networks, which he founded in 1993 and served as CEO until it was acquired by the Rockefeller Group in 2003. He continued as president of Rockefeller Group Technology Services Mid Atlantic, a member of Rockefeller Group International until 2004. Earlier in his career, he served as a management consultant with Arthur Andersen Consulting (now Accenture). Gordon received his B.S. in Business Administration and MBA in Finance from American University.

About Odyssey Marine Exploration

Odyssey Marine Exploration, Inc. (Nasdaq:OMEX) is engaged in deep-ocean exploration using innovative methods and state of-the-art technology for shipwreck projects and mineral exploration. Odyssey's work has been featured in more than 16 hours of prime-time TV programming on Discovery Channel, National Geographic programming on PBS, NBC, and MSNBC as well as National Geographic Magazine and other national publications. More than 2 million people have been educated and entertained by Odyssey's traveling exhibit, which features more than 500 authentic artifacts. The company has also published 42 archaeological and scientific papers available at no cost online or in four volumes of hardbound Oceans Odyssey books. Shipwreck history and artifact information is also available to people around the globe at OdysseysVirtualMuseum.com.

For additional details about Odyssey, visit www.odysseymarine.com. You can also follow the company on Facebook (www.facebook.com/OdysseyMarine) and Twitter (@OdysseyMarine).

Important Cautions Regarding Forward Looking Information

Odyssey Marine Exploration believes the information set forth in this Press Release may include "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in "Risk Factors" in Part I, Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2013, which was filed with the Securities and Exchange Commission on March 17, 2014. The financial and operating projections as well as estimates of mining assets are based solely on the assumptions developed by Odyssey that it believes are reasonable based upon information available to Odyssey as of the date of this release. All projections and estimates are subject to material uncertainties, and should not be viewed as a prediction or an assurance of actual future performance. The validity and accuracy of Odyssey's projections will depend upon unpredictable future events, many of which are beyond Odyssey's control and, accordingly, no assurance can be given that Odyssey's assumptions will prove true or that its projected results will be achieved.

CONTACT: MEDIA CONTACT:

Liz Shows

Odyssey Marine Exploration, Inc.

(813) 876-1776 x 2335

lshows@odysseymarine.com



INVESTOR RELATIONS CONTACT:

Ron Both

Liolios Group, Inc.

(949) 574-3860

OMEX@liolios.com
OME logo

Source: Odyssey Marine Exploration, Inc.

Producing a spray containing THC using its patented oral spray delivery system, and existing proprietary formulas. Working with several firms already in the business, in order to manufacture and deliver the product in several legal jurisdictions.

http://cannabissativa.co/companies/northstar-global-business-services-inc

Umbilical Cord Blood Banking Market: Global Industry Analysis and Forecast to 2020 by Persistence Market Research

Persistence Market Research Released New Market Report on “Umbilical Cord Blood Banking Market” in category "Healthcare"

New York, NY -- (ReleaseWire) -- 09/12/2014 -- Biopreservation involves various techniques such as hypothermic storage, vitrification and cryopreservation in laboratory and clinical environment. Increase in demand for cell-banking systems, such as umbical cord banking, tissue banking and cell banking, has led to increase in the biopreservation market with a high growth rate. Umbilical Cord Blood Banking is a technique involving collection and storage of baby’s umbical cord cells and tissues in an appropriate environment to preserve it with sustained integrity. It is done as a result of potential stored in blood cells of umbical cord, that when required, these cells can be used to create new tissue or organs. This can help a person in fighting against various diseases and deficiencies.

Read more: http://www.digitaljournal.com/pr/2184198#ixzz3EqcMEg4A

Medical Marijuana Goes Solar in Michigan
Sep 8, 2014 - http://pvsolarreport.com/medical-marijuana-goes-solar-in-michigan/

Solar’s popularity among agribusinesses is no longer confined to the more traditional ones. As the marijuana industry continues to expand across the country, many growers are making the decision to go solar.

In the past, when marijuana was completely a black market commodity, growers were forced to use banks of solar panels and battery backups to avoid detection of their operation. Utilities would notice large spikes in electricity usage and send the data to police for investigation. Avoiding arrest was the primary motivation for marijuana growers to go solar.

Today, 23 states have legalized marijuana for medicinal use, and most allow for its cultivation. Nationwide, the taxed marijuana market is worth $1.5 billion, according to a November 2013 report from ArcView Market Research. Because of the plant’s widespread cultivation across the country, the massive consumption of electricity by the high-intensity lights used poses a new problem for local utilities.

In Michigan, an electrical engineer (who wishes to remain anonymous) decided to join the medical marijuana market. Shortly after he began cultivating several dozen marijuana plants indoors, the local utility contacted him and expressed concern about his high electricity usage. That prompted him to reach out to NovoFuel to look into renewable energy options.

NovoFuel, a wholly owned subsidiary of AlumiFuel Power Corporation (OTCPK: AFPW), designed the Michigan marijuana grow operation to generate 10 kW of electricity from wind turbines and 12 kW from 44 solar panels. This system will provide half of the operation’s electrical energy needs. The energy backup comes from an 18.6 kW lithium ion battery.

Potential Buyout? Big Time Investor? Is it possible that a major corporation or a big time finance company step in to revive this company? Something must be wrong with the product or the people managing this product. From the website, videos and articles I had read seeing this ship sinking right now is sad. Big Potential ---- High Risk to Play this right now without some sort of news. Last we have all heard was they are broke and cannot pay on their debt, most say the company is closed and no employees. However, the website is still up and running and the phone is connected accepting calls. Whats going on here?

Forecasts Sierra World Equity Review

http://sierraworldequityreview.blogspot.com/2014/09/redmond-meetingsnustate-energy-holdings.html

Redmond Meetings_NuState Energy Holdings (NSEH) Talking Joint Ventures With Microsoft (MSFT) Forecasts Sierra World Equity Review
Latest Projections: Redmond Meetings_NuState Energy Holdings (NSEH) Talking Joint Ventures With Microsoft (MSFT) Forecasts Sierra World Equity Review. Shares of NSEH were trading lower down over 17% during Tuesday's session. Look for the official news, when it breaks remember Sierra called this first!

http://sierraworldequityreview.blogspot.com/2014/09/redmond-meetingsnustate-energy-holdings.html

Websites? Products? Confused :(

I like a good MJ Play, however this one has me a little confused. Websites all appear to be down, not found, error, etc. The main web page is just a "coming soon" message for a Green Card. Any recent news on what the heck this company is doing with their pharama Vending machines? What happened to that concept?

Last week this stock was on high alert, now .................

The Wyoming Flexibility and Convenience Advantage: Pro-Owner and Pro-Convenience Legal System

Wyoming’s legislature understands the needs of business owners and intentionally designed their corporate law to be pro-convenience and pro-owner. Wyoming offers a wealth of features that bring flexibility, convenience, and time savings to Corporation and Limited Liability Company management:

Wyoming is a “sole owner” state; Wyoming allows one individual to serve as the stockholder, director, president, secretary and treasurer. The sole owner rule applies to both Corporations and Limited Liability Companies. Some states require at least two officers and/or at least three directors. For a sole owner business, having multiple officers and directors may serve to drain time and resources. Wyoming’s sole owner rules ensure flexibility and efficiency.
Wyoming allows Corporations to charter with unlimited authorized shares. Corporations are normally bound by the number of authorized shares set forth in their articles of incorporation. If a Corporation exceeds the number of authorized shares designated in the articles, the Corporation must scramble to amend the articles to increase the number of authorized shares. Wyoming’s unlimited authorized shares option gives Corporations unlimited room for growth.

Wyoming is a “written consent” state; Wyoming gives owners and managers a wide degree flexibility to take corporate actions by written consent. A written consent is a binding, written resolution adopted by either the shareholders or directors of a corporation approving a particular corporate action. A written consent is a more convenient and less time-consuming alternative than the more burdensome method of calling, noticing, and conducting formal meetings of management and shareholders.
Wyoming Corporations (and Limited Liability Companies) may issue stock for nearly any sort of consideration: capital investment, services, personal property, or real estate, including leases and options. Not all states grant such power to a Corporation. This freedom allows Wyoming Corporations to issue shares for the services of employees and consultants. The Corporation’s directors may determine the value of any of these transactions, and their decision cannot be challenged. This rule is advantageous to organizers of companies–it gives them the power to adjust stock ownership as they see fit.
A Wyoming Corporation may purchase, own, hold, sell, transfer, pledge, or assign shares of its own stock. Not all states allow Corporations to own or transfer their own shares. This power brings valuable flexibility to the Wyoming business owner.
A Wyoming Corporation or Limited Liability Company can transfer stock instantly and privately, without any public notification or state filing. This is a further privacy protection that Wyoming Corporations, LLCs, and business owners enjoy.
Unlike some states, Wyoming does not impose a minimum capital investment requirement. As such, you need no minimum investment to form a Wyoming Limited Liability Company or Corporation. You can form a Wyoming Corporation or LLC with as little as $10 of capital–and no state authority will ever question the amount of initial investment made to the entity.
Wyoming has wisely organized the Secretary of State’s office into an efficient and effective customer service organization. The Secretary of State’s Web site is informative and easy to navigate. The searchable database allows one to quickly check on the status of one’s own Corporation or Limited Liability Company. Is one’s entity overdue in its annual report? Is one’s entity in good standing with the Secretary of State’s office? A simple check on the web will answer these questions. Annual reports can be done in seconds, right from your computer.
Directors and officers of Wyoming Corporations enjoy generous protection (sometimes called “indemnity”) from personal liability to the Corporation or to a Corporation’s shareholders in connection with their service to the Corporation.
A Wyoming Corporation or Limited Liability Company can be headquartered anywhere in the world. In fact, a Wyoming Corporation or Limited Liability Company is not required to maintain its records in Wyoming. Wyoming merely requires one Wyoming address: the address of your registered agent. Even non-U.S. citizens can form and own a Wyoming Corporation.

http://www.gimmelaw.com/wyoming-incorporation-advantages-wyoming-corporation-advantages-personal-privacy-and-asset-protection

GO $PFNO #18 on the Breakout Board (Let's get something going here)